The big question right now is: Can artificial intelligence – also known as AI - change how scientist discover new medicines?

Yes - According to new research from scientists at Janssen who've found a way to speed up the drug discovery process using AI.

It’s no secret that Janssen has been at the forefront of treatment innovation for decades. In fact, Dr. Paul Janssen, the Belgian physician who founded our company in 1953, discovered and developed dozens of lifesaving medications throughout his career.

Traditionally, the process of discovering new medicines takes years, due to the vast amount of data scientists must comb through to first identify the chemical compounds that are most likely to help treat a targeted disease—before they can even begin testing their effectiveness.

But a recent paper published in the journal Cell Chemical Biology presented an exciting development when it comes to drug discovery: Janssen scientists have found a new way to leverage AI - using computer systems to perform certain tasks that normally require human intelligence, also known as "machine learning"—to help speed up the process.

This article, written by Kaitlin Ahern, first appeared on www.jnj.com. Read the full article here.